Is Human fibrinogen registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 3 valid registrations of Human fibrinogen, including Fibryga (1 g, Powder for solution for injection/infusion, SAR 1878.95); Haemocomplettan P (1 g, Powder for solution for injection/infusion, SAR 2034.20); Haemocomplettan P (2 g, Powder for solution for injection/infusion, SAR 4068.55).

Active substance

Human fibrinogen

SFDA 3

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Fibryga	1 g	Powder for solution for injection/infusion · Intravenous use	1 Vial	SAR 1878.95	Biological · Prescription	OCTAPHARMA	Valid
Haemocomplettan P	1 g	Powder for solution for injection/infusion · Intravenous use	1 Vial	SAR 2034.20	Biological · Prescription	CSL	Valid
Haemocomplettan P	2 g	Powder for solution for injection/infusion · Intravenous use	1 Vial	SAR 4068.55	Biological · Prescription	CSL	Valid

Combinations containing Human fibrinogen

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.